IL126416A - Cultured inner cell mass cell lines derived from ungulate embryos - Google Patents

Cultured inner cell mass cell lines derived from ungulate embryos

Info

Publication number: IL126416A
Authority: IL; Israel
Prior art keywords: cells; cell; cicm; icm; cultured
Prior art date: 1996-04-01

Application number

IL12641697A

Other languages

English (en)

Other versions

IL126416A0 (en

Original Assignee

Univ Massachusetts

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-04-01

Filing date

1997-03-24

Publication date

2004-06-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24508762&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL126416(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-03-24 Application filed by Univ Massachusetts filed Critical Univ Massachusetts

1999-05-09 Publication of IL126416A0 publication Critical patent/IL126416A0/xx

2004-06-20 Publication of IL126416A publication Critical patent/IL126416A/en

Links

210000002257 embryonic structure Anatomy 0.000 title claims abstract description 65
238000000034 method Methods 0.000 claims abstract description 75
238000012258 culturing Methods 0.000 claims abstract description 31
241000283690 Bos taurus Species 0.000 claims abstract description 28
238000004519 manufacturing process Methods 0.000 claims abstract description 25
241000282887 Suidae Species 0.000 claims abstract description 5
210000004027 cell Anatomy 0.000 claims description 450
239000010410 layer Substances 0.000 claims description 71
210000002950 fibroblast Anatomy 0.000 claims description 44
102000002260 Alkaline Phosphatase Human genes 0.000 claims description 31
108020004774 Alkaline Phosphatase Proteins 0.000 claims description 31
210000002459 blastocyst Anatomy 0.000 claims description 23
230000000877 morphologic effect Effects 0.000 claims description 23
210000001519 tissue Anatomy 0.000 claims description 12
108010066327 Keratin-18 Proteins 0.000 claims description 11
102000018329 Keratin-18 Human genes 0.000 claims description 11
241001529936 Murinae Species 0.000 claims description 10
210000000130 stem cell Anatomy 0.000 claims description 10
108090000631 Trypsin Proteins 0.000 claims description 9
102000004142 Trypsin Human genes 0.000 claims description 9
230000001086 cytosolic effect Effects 0.000 claims description 9
239000012588 trypsin Substances 0.000 claims description 9
241001494479 Pecora Species 0.000 claims description 8
210000003674 cytoplasmic vesicle Anatomy 0.000 claims description 8
230000006799 invasive growth in response to glucose limitation Effects 0.000 claims description 7
239000002356 single layer Substances 0.000 claims description 7
230000002255 enzymatic effect Effects 0.000 claims description 5
239000011521 glass Substances 0.000 claims description 5
210000001161 mammalian embryo Anatomy 0.000 claims description 5
238000011282 treatment Methods 0.000 claims description 4
241000283707 Capra Species 0.000 claims description 3
108010059712 Pronase Proteins 0.000 claims description 3
239000000126 substance Substances 0.000 claims description 3
241000283086 Equidae Species 0.000 claims description 2
230000015572 biosynthetic process Effects 0.000 claims description 2
238000003825 pressing Methods 0.000 claims 1
238000012546 transfer Methods 0.000 abstract description 22
108020004414 DNA Proteins 0.000 abstract description 18
210000003754 fetus Anatomy 0.000 abstract description 13
230000009261 transgenic effect Effects 0.000 abstract description 10
230000002035 prolonged effect Effects 0.000 abstract description 7
238000002360 preparation method Methods 0.000 abstract description 4
108090000623 proteins and genes Proteins 0.000 description 47
230000014509 gene expression Effects 0.000 description 20
241000282898 Sus scrofa Species 0.000 description 15
239000001963 growth medium Substances 0.000 description 13
102000011782 Keratins Human genes 0.000 description 12
108010076876 Keratins Proteins 0.000 description 12
241001465754 Metazoa Species 0.000 description 12
230000000694 effects Effects 0.000 description 11
230000001939 inductive effect Effects 0.000 description 11
238000002955 isolation Methods 0.000 description 11
230000004069 differentiation Effects 0.000 description 10
230000001976 improved effect Effects 0.000 description 9
210000004940 nucleus Anatomy 0.000 description 9
210000004748 cultured cell Anatomy 0.000 description 8
230000002401 inhibitory effect Effects 0.000 description 8
210000002308 embryonic cell Anatomy 0.000 description 7
238000000338 in vitro Methods 0.000 description 7
244000144972 livestock Species 0.000 description 7
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 6
238000000926 separation method Methods 0.000 description 6
241000894007 species Species 0.000 description 6
230000002411 adverse Effects 0.000 description 5
239000002771 cell marker Substances 0.000 description 5
-1 e.g. Proteins 0.000 description 5
210000004602 germ cell Anatomy 0.000 description 5
238000000520 microinjection Methods 0.000 description 5
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
238000011161 development Methods 0.000 description 4
230000018109 developmental process Effects 0.000 description 4
210000002242 embryoid body Anatomy 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
239000002609 medium Substances 0.000 description 4
210000000056 organ Anatomy 0.000 description 4
210000002966 serum Anatomy 0.000 description 4
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
102100026189 Beta-galactosidase Human genes 0.000 description 3
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 3
108010005774 beta-Galactosidase Proteins 0.000 description 3
230000024245 cell differentiation Effects 0.000 description 3
230000003413 degradative effect Effects 0.000 description 3
210000002919 epithelial cell Anatomy 0.000 description 3
230000002068 genetic effect Effects 0.000 description 3
230000012010 growth Effects 0.000 description 3
210000003958 hematopoietic stem cell Anatomy 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
238000010449 nuclear transplantation Methods 0.000 description 3
210000000287 oocyte Anatomy 0.000 description 3
DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 2
241000287828 Gallus gallus Species 0.000 description 2
241000282412 Homo Species 0.000 description 2
108010050904 Interferons Proteins 0.000 description 2
102000014150 Interferons Human genes 0.000 description 2
102100021747 Leukemia inhibitory factor receptor Human genes 0.000 description 2
101710142062 Leukemia inhibitory factor receptor Proteins 0.000 description 2
102000003792 Metallothionein Human genes 0.000 description 2
108090000157 Metallothionein Proteins 0.000 description 2
102000043276 Oncogene Human genes 0.000 description 2
108700020796 Oncogene Proteins 0.000 description 2
241000283903 Ovis aries Species 0.000 description 2
101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 2
206010034133 Pathogen resistance Diseases 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
108091027981 Response element Proteins 0.000 description 2
239000004098 Tetracycline Substances 0.000 description 2
108091023040 Transcription factor Proteins 0.000 description 2
102000040945 Transcription factor Human genes 0.000 description 2
108700019146 Transgenes Proteins 0.000 description 2
239000000427 antigen Substances 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
238000004364 calculation method Methods 0.000 description 2
244000309466 calf Species 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
239000013553 cell monolayer Substances 0.000 description 2
238000010367 cloning Methods 0.000 description 2
239000003636 conditioned culture medium Substances 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000010494 dissociation reaction Methods 0.000 description 2
230000005593 dissociations Effects 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000008143 early embryonic development Effects 0.000 description 2
230000001605 fetal effect Effects 0.000 description 2
238000010874 in vitro model Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
230000006698 induction Effects 0.000 description 2
229940079322 interferon Drugs 0.000 description 2
238000002350 laparotomy Methods 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
239000003550 marker Substances 0.000 description 2
229910021645 metal ion Inorganic materials 0.000 description 2
229960004857 mitomycin Drugs 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
239000000047 product Substances 0.000 description 2
230000001902 propagating effect Effects 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
210000005000 reproductive tract Anatomy 0.000 description 2
239000000243 solution Substances 0.000 description 2
150000003431 steroids Chemical class 0.000 description 2
229960005322 streptomycin Drugs 0.000 description 2
239000013589 supplement Substances 0.000 description 2
229960002180 tetracycline Drugs 0.000 description 2
229930101283 tetracycline Natural products 0.000 description 2
235000019364 tetracycline Nutrition 0.000 description 2
150000003522 tetracyclines Chemical class 0.000 description 2
238000002054 transplantation Methods 0.000 description 2
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
VLEIUWBSEKKKFX-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O VLEIUWBSEKKKFX-UHFFFAOYSA-N 0.000 description 1
OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
208000030507 AIDS Diseases 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
108700003860 Bacterial Genes Proteins 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
241000701022 Cytomegalovirus Species 0.000 description 1
208000035240 Disease Resistance Diseases 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
102100028073 Fibroblast growth factor 5 Human genes 0.000 description 1
108090000380 Fibroblast growth factor 5 Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
108700005087 Homeobox Genes Proteins 0.000 description 1
101001002170 Homo sapiens Glutamine amidotransferase-like class 1 domain-containing protein 3, mitochondrial Proteins 0.000 description 1
101000572981 Homo sapiens POU domain, class 3, transcription factor 1 Proteins 0.000 description 1
101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 description 1
101000713275 Homo sapiens Solute carrier family 22 member 3 Proteins 0.000 description 1
101000595467 Homo sapiens T-complex protein 1 subunit gamma Proteins 0.000 description 1
101000843556 Homo sapiens Transcription factor HES-1 Proteins 0.000 description 1
208000023105 Huntington disease Diseases 0.000 description 1
241000592718 Ibla Species 0.000 description 1
206010061598 Immunodeficiency Diseases 0.000 description 1
102100040487 Keratin, type I cytoskeletal 13 Human genes 0.000 description 1
108010065070 Keratin-13 Proteins 0.000 description 1
102100032352 Leukemia inhibitory factor Human genes 0.000 description 1
108090000581 Leukemia inhibitory factor Proteins 0.000 description 1
108010074338 Lymphokines Proteins 0.000 description 1
102000008072 Lymphokines Human genes 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
108091028043 Nucleic acid sequence Proteins 0.000 description 1
208000018737 Parkinson disease Diseases 0.000 description 1
102000011755 Phosphoglycerate Kinase Human genes 0.000 description 1
102100020949 Putative glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial Human genes 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
235000017276 Salvia Nutrition 0.000 description 1
241001072909 Salvia Species 0.000 description 1
102100021543 Solute carrier family 22 member 16 Human genes 0.000 description 1
102100036049 T-complex protein 1 subunit gamma Human genes 0.000 description 1
101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000003409 anti-rejection Effects 0.000 description 1
235000013405 beer Nutrition 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000037396 body weight Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000008366 buffered solution Substances 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
238000003320 cell separation method Methods 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
238000009795 derivation Methods 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
210000001671 embryonic stem cell Anatomy 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
239000003797 essential amino acid Substances 0.000 description 1
235000020776 essential amino acid Nutrition 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
238000012239 gene modification Methods 0.000 description 1
230000005017 genetic modification Effects 0.000 description 1
235000013617 genetically modified food Nutrition 0.000 description 1
239000008103 glucose Substances 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
230000010354 integration Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
108010042502 laminin A Proteins 0.000 description 1
LFEUVBZXUFMACD-UHFFFAOYSA-H lead(2+);trioxido(oxo)-$l^{5}-arsane Chemical compound [Pb+2].[Pb+2].[Pb+2].[O-][As]([O-])([O-])=O.[O-][As]([O-])([O-])=O LFEUVBZXUFMACD-UHFFFAOYSA-H 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
239000002502 liposome Substances 0.000 description 1
210000005229 liver cell Anatomy 0.000 description 1
208000019423 liver disease Diseases 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
238000005259 measurement Methods 0.000 description 1
238000010297 mechanical methods and process Methods 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
239000002184 metal Substances 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000000203 mixture Substances 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
210000000633 nuclear envelope Anatomy 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
125000003835 nucleoside group Chemical group 0.000 description 1
238000005457 optimization Methods 0.000 description 1
210000004789 organ system Anatomy 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
238000007747 plating Methods 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
230000008569 process Effects 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000001850 reproductive effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
238000011895 specific detection Methods 0.000 description 1
238000010186 staining Methods 0.000 description 1
230000008093 supporting effect Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
210000002993 trophoblast Anatomy 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
239000013598 vector Substances 0.000 description 1
238000002689 xenotransplantation Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
- C12N15/877—Techniques for producing new mammalian cloned embryos
- C12N15/8771—Bovine embryos
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Zoology (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Wood Science & Technology (AREA)
Developmental Biology & Embryology (AREA)
General Health & Medical Sciences (AREA)
General Engineering & Computer Science (AREA)
Gynecology & Obstetrics (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Reproductive Health (AREA)
Cell Biology (AREA)
Environmental Sciences (AREA)
Animal Husbandry (AREA)
Animal Behavior & Ethology (AREA)
Biodiversity & Conservation Biology (AREA)
Veterinary Medicine (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Plant Pathology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)

IL12641697A 1996-04-01 1997-03-24 Cultured inner cell mass cell lines derived from ungulate embryos IL126416A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/626,054 US5905042A (en)	1996-04-01	1996-04-01	Cultured inner cell mass cell lines derived from bovine or porcine embryos
PCT/US1997/004736 WO1997037009A1 (en)	1996-04-01	1997-03-24	Cultured inner cell mass cell lines derived from ungulate embryos

Publications (2)

Publication Number	Publication Date
IL126416A0 IL126416A0 (en)	1999-05-09
IL126416A true IL126416A (en)	2004-06-20

Family

ID=24508762

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12641697A IL126416A (en)	1996-04-01	1997-03-24	Cultured inner cell mass cell lines derived from ungulate embryos

Country Status (13)

Country	Link
US (1)	US5905042A (de)
EP (1)	EP0938550B1 (de)
JP (1)	JP2000507827A (de)
CN (1)	CN100335625C (de)
AT (1)	ATE318307T1 (de)
AU (1)	AU717529B2 (de)
BR (1)	BR9710652A (de)
CA (1)	CA2250834A1 (de)
DE (1)	DE69735293T2 (de)
ES (1)	ES2259189T3 (de)
IL (1)	IL126416A (de)
NZ (1)	NZ332159A (de)
WO (1)	WO1997037009A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5480772A (en)	1993-02-03	1996-01-02	Brandeis University	In vitro activation of a nucleus
US5523226A (en) *	1993-05-14	1996-06-04	Biotechnology Research And Development Corp.	Transgenic swine compositions and methods
US5905042A (en) *	1996-04-01	1999-05-18	University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus	Cultured inner cell mass cell lines derived from bovine or porcine embryos
US5994619A (en) *	1996-04-01	1999-11-30	University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus	Production of chimeric bovine or porcine animals using cultured inner cell mass cells
US20060021070A1 (en) *	1996-04-01	2006-01-26	University of Massachusetts, a Public Institution of Higher Education of the Commonwealth of MA	Production of chimeric bovine or porcine animals using cultured inner cell mass
US7696404B2 (en) *	1996-08-19	2010-04-13	Advanced Cell Technology, Inc.	Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
US6235969B1 (en) *	1997-01-10	2001-05-22	University Of Massachusetts	Cloning pigs using donor nuclei from non-quiescent differentiated cells
US6215041B1 (en)	1997-01-10	2001-04-10	University Of Mmassachusetts	Cloning using donor nuclei from a non-quiesecent somatic cells
US5945577A (en) *	1997-01-10	1999-08-31	University Of Massachusetts As Represented By Its Amherst Campus	Cloning using donor nuclei from proliferating somatic cells
GB9703550D0 (en) *	1997-02-20	1997-04-09	Ppl Therapeutics Scotland Ltd	Cell mediated transgenesis
US6011197A (en)	1997-03-06	2000-01-04	Infigen, Inc.	Method of cloning bovines using reprogrammed non-embryonic bovine cells
US6331659B1 (en)	1998-01-21	2001-12-18	University Of Hawaii	Cumulus cells as nuclear donors
BR9908499A (pt) *	1998-03-02	2001-12-26	Univ Massachusetts Public Inst	Linhagens celulares embrionárias ousemelhantes a tronco produzidas portransplante nuclear de espécies cruzado
GB9811859D0 (en) *	1998-06-02	1998-07-29	Biotech & Biolog Scien Res	Biological manipulation
CA2340242A1 (en) *	1998-08-11	2000-02-24	Teruhiko Wakayama	Method of performing transgenesis
US6781030B1 (en)	1998-11-02	2004-08-24	Trustee Of Tufts College, Ballou Hall	Methods for cloning mammals using telophase oocytes
US6700037B2 (en)	1998-11-24	2004-03-02	Infigen, Inc.	Method of cloning porcine animals
US6258998B1 (en)	1998-11-24	2001-07-10	Infigen, Inc.	Method of cloning porcine animals
NZ514620A (en)	1999-03-04	2004-04-30	Ppl Therapeutics Scotland Ltd	Genetic modification of somatic cells and uses thereof
EP1206525B1 (de)	1999-08-24	2008-11-12	Una Chen-Bettecken	Verfahren zur vermehrung von stammzellen
CN1377225A (zh) *	1999-09-13	2002-10-30	马萨诸塞大学	使用来自分化细胞的供体细胞或细胞核克隆猪以及多能猪的生成
MXPA02004233A (es)	1999-10-28	2004-02-17	Univ Massachusetts	Produccion ginogenetica o androgenetica de celulas pluripotentes y lineas celulares, y uso de las mismas para producir celulas diferenciadas y tejidos.
GB2360522A (en)	2000-03-24	2001-09-26	Geron Corp	A strategy for maintaining pregnancy
EA013564B1 (ru)	2000-08-03	2010-06-30	Терапеутик Хьюман Поликлоналз Инк.	Гуманизированный иммуноглобулин и содержащая его фармацевтическая композиция
US20030027331A1 (en) *	2000-11-30	2003-02-06	Yan Wen Liang	Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
AU2001297880B2 (en) *	2000-11-30	2007-05-31	Stemron Inc.	Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
US7491534B2 (en) *	2000-12-22	2009-02-17	Kirin Holdings Kabushiki Kaisha	Methods for altering cell fate to generate T-cells specific for an antigen of interest
US20020142397A1 (en) *	2000-12-22	2002-10-03	Philippe Collas	Methods for altering cell fate
MXPA03005624A (es) *	2000-12-22	2004-12-03	Vaurox Llc	Metodos para clonar mamiferos usando cromatina reprogramada del donador o celulas donadoras.
KR20030088023A (ko)	2001-01-02	2003-11-15	스템론 인크.	미리 선별된 면역형 및(또는) 유전자형을 갖는 동형접합성간세포 군집의 제조 방법, 그로부터 유래된 이식에 적합한세포, 및 이들을 사용하는 재료 및 방법
WO2002073188A1 (en) *	2001-03-13	2002-09-19	Advanced Cell Technology, Inc.	Method for generating replacement cells and/or tissues
WO2002078449A2 (en) *	2001-04-02	2002-10-10	Advanced Cell Technology, Inc.	Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
US6830917B2 (en)	2001-12-10	2004-12-14	Baxter Healthcare S.A.	Method of isolation and purification of trypsin from pronase protease and use thereof
JP2005512593A (ja) *	2001-12-28	2005-05-12	セルアーティスアーベー	多能性のヒト胚盤胞由来幹細胞株の樹立方法
US20030134422A1 (en) *	2002-01-16	2003-07-17	Sayre Chauncey Bigelow	Stem cell maturation for all tissue lines
US20050170506A1 (en) *	2002-01-16	2005-08-04	Primegen Biotech Llc	Therapeutic reprogramming, hybrid stem cells and maturation
US20050090004A1 (en) *	2003-01-16	2005-04-28	Sayre Chauncey B.	Stem cell maturation for all tissue lines
US7612250B2 (en)	2002-07-29	2009-11-03	Trustees Of Tufts College	Nuclear transfer embryo formation method
EP1615492A4 (de)	2003-04-09	2010-07-14	Magee Womens Health Corp	Verfahren zur korrektur von mitose-spindeldefekten beim somatischen zellkerntransfer bei tieren
US8552254B2 (en)	2003-08-22	2013-10-08	The Jackson Laboratory	Methods for maintaining genetic stability of inbred animal strains
JP5072359B2 (ja)	2003-08-22	2012-11-14	ザジャクソンラボラトリー	近交系動物の遺伝的安定性を維持するための方法
US20050272149A1 (en)	2004-06-02	2005-12-08	Life & Brain Gmbh	Therapeutic delivery of adenosine into a tissue
US20060188491A1 (en) *	2004-07-15	2006-08-24	Primegen Biotech, Llc	Use of nuclear material to therapeutically reprogram differentiated cells
WO2006041910A2 (en) *	2004-10-05	2006-04-20	Trustees Of The University Of Pennsylvania	Stem cells derived from uniparental embryos and methods of use thereof
KR20080025366A (ko)	2005-04-29	2008-03-20	텐딕스 디벨롭먼트, 엘엘씨	래디얼 임펄스 엔진, 펌프 및 압축기 시스템과 관련 동작방법
NZ563603A (en) *	2005-04-29	2010-10-29	Innovative Dairy Products Pty	A method for producing stem cells or stem cell-like cells from mammalian embryos
JP2010507373A (ja) *	2006-10-24	2010-03-11	アデレードリサーチアンドイノベイションピーティーワイエルティーディー	動物血清を含まない培地中で着床前胚から多能性細胞を単離するための方法
WO2008085891A1 (en) *	2007-01-05	2008-07-17	Worcester Polytechnic Institute	Oocyte spindle-associated factors improve somatic cell cloning
WO2010108503A1 (en)	2009-03-24	2010-09-30	Life & Brain Gmbh	Promotion of neuronal integration in neural stem cell grafts
CA2895204C (en) *	2012-10-19	2022-06-28	Trans Ova Genetics, L.C.	Methods for generating genetically superior animals
AU2014248167B2 (en)	2013-04-03	2019-10-10	FUJIFILM Cellular Dynamics, Inc.	Methods and compositions for culturing endoderm progenitor cells in suspension
EP3207122B1 (de)	2014-10-14	2019-05-08	FUJIFILM Cellular Dynamics, Inc.	Erzeugung von keratinozyten aus pluripotenten stammzellen und erhaltung von keratinozytenkulturen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH04500909A (ja) *	1988-09-21	1992-02-20	アニマル　バイオテクノロジー　ケンブリッジ　リミティド	家畜からの多能性胚細胞系の誘導
GB9003791D0 (en) *	1990-02-20	1990-04-18	Ludwig Inst Cancer Res	Transgenic animals,cell lines therefrom,and their use
US5523226A (en) *	1993-05-14	1996-06-04	Biotechnology Research And Development Corp.	Transgenic swine compositions and methods
JPH09500526A (ja) *	1993-06-14	1997-01-21	ベーアーエスエフアクツィエンゲゼルシャフト	テトラサイクリン反応性プロモーターによる真核細胞の遺伝子発現の厳密な制御
US5905042A (en) *	1996-04-01	1999-05-18	University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus	Cultured inner cell mass cell lines derived from bovine or porcine embryos

1996
- 1996-04-01 US US08/626,054 patent/US5905042A/en not_active Expired - Fee Related
1997
- 1997-03-24 JP JP9535351A patent/JP2000507827A/ja active Pending
- 1997-03-24 IL IL12641697A patent/IL126416A/en not_active IP Right Cessation
- 1997-03-24 BR BR9710652-6A patent/BR9710652A/pt not_active Application Discontinuation
- 1997-03-24 EP EP97915189A patent/EP0938550B1/de not_active Expired - Lifetime
- 1997-03-24 WO PCT/US1997/004736 patent/WO1997037009A1/en not_active Ceased
- 1997-03-24 AT AT97915189T patent/ATE318307T1/de not_active IP Right Cessation
- 1997-03-24 NZ NZ332159A patent/NZ332159A/en unknown
- 1997-03-24 CA CA002250834A patent/CA2250834A1/en not_active Abandoned
- 1997-03-24 AU AU22194/97A patent/AU717529B2/en not_active Ceased
- 1997-03-24 ES ES97915189T patent/ES2259189T3/es not_active Expired - Lifetime
- 1997-03-24 DE DE69735293T patent/DE69735293T2/de not_active Expired - Fee Related
- 1997-03-24 CN CNB971947554A patent/CN100335625C/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL126416A0 (en)	1999-05-09
DE69735293T2 (de)	2006-11-02
EP0938550A4 (de)	2001-08-08
DE69735293D1 (de)	2006-04-27
CA2250834A1 (en)	1997-10-09
AU2219497A (en)	1997-10-22
ATE318307T1 (de)	2006-03-15
BR9710652A (pt)	2000-01-11
ES2259189T3 (es)	2006-09-16
CN1219198A (zh)	1999-06-09
EP0938550B1 (de)	2006-02-22
CN100335625C (zh)	2007-09-05
AU717529B2 (en)	2000-03-30
US5905042A (en)	1999-05-18
JP2000507827A (ja)	2000-06-27
WO1997037009A1 (en)	1997-10-09
NZ332159A (en)	2000-02-28
EP0938550A1 (de)	1999-09-01

Legal Events

Date	Code	Title
2004-11-24	FF	Patent granted
2005-02-20	KB	Patent renewed
2008-01-06	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
EP0938550B1 (de)	2006-02-22	Kultur einer zelllinieaus der inneren zellmasse von huftierembryonen.
US5994619A (en)	1999-11-30	Production of chimeric bovine or porcine animals using cultured inner cell mass cells
US6395958B1 (en)	2002-05-28	Method of producing a polypeptide in an ungulate
AU745334B2 (en)	2002-03-21	Method of cloning animals
US20050210537A1 (en)	2005-09-22	Pluripotent mammalian cells
US6194635B1 (en)	2001-02-27	Embryonic germ cells, method for making same, and using the cells to produce a chimeric porcine
US6545199B1 (en)	2003-04-08	Embryonic germ cells, method for making same, and using the cells to produce a chimeric porcine
US7652192B2 (en)	2010-01-26	Cloning of transgenic unglulates comprising artificial chromosomes
AU2002252076A1 (en)	2003-03-06	Cloning of transgenic animals comprising artificial chromosomes
US20060021070A1 (en)	2006-01-26	Production of chimeric bovine or porcine animals using cultured inner cell mass
JP2005523685A (ja)	2005-08-11	体細胞由来胚幹細胞及びそれらの分化子孫
EP0855441A2 (de)	1998-07-29	Isolierung und Reinigung von Stammzellen mit magnetischen Kugeln, die wie Antikörper funktionieren, und Verfahren zur Preparation einer Stammzellinie
MXPA98008103A (en)	1999-06-01	Cellular lines of internal cellular mass cultivated derivatives of embryos ungula
WO2005040361A1 (ja)	2005-05-06	幹細胞の簡易調製法およびそれに使用するフィーダー細胞
AU782358B2 (en)	2005-07-21	Method of cloning animals
HK1019769A (en)	2000-02-25	Cultured inner cell mass cell lines derived from ungulate embryos
EP1611785A1 (de)	2006-01-04	Klonieren von transgenen Huftieren mit künstlichen Chromosomen